In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Faux foie gras firm forms foodie panel
In Paris, cultivated meat startup Gourmey has formed what it claims is the culinary industry’s first-ever advisory board dedicated to cultivated meat.
The panel...
Celleste Bio secures $4.5 million for cell-cultured cocoa
In Israel, cell cultured cocoa startup Celleste Bio has raised $4.5 million in a seed funding round. The funds will boost the company's research...
Wrapped up: Origami inspires paperboard packaging solution
In Finland, researchers from VTT and Aalto University are applying origami, the ancient Japanese art of paper folding, to the plastics waste crisis.
Led...